Aberrant tryptophan metabolism leads to unfavorable outcomes in lenalidomide-treated myeloma patients.
Asano A, Ri M, Masaki A, Maeda Y, Tachita T, Hirade K, Marumo Y, Nakashima T, Hagiwara S, Kinoshita S, Suzuki T, Narita T, Kusumoto S, Komatsu H, Inagaki H, Iida S.
Asano A, et al. Among authors: iida s.
Hematol Oncol. 2023 Aug;41(3):424-433. doi: 10.1002/hon.3108. Epub 2022 Dec 2.
Hematol Oncol. 2023.
PMID: 36426594